997HA307 - Previously Treated Subjects With Severe Haemophilia A

• Research type

  Research Study

• Full title

  A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of 2 Vial Strengths of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc; BIIB031) in Previously Treated Subjects With Severe Hemophilia A

• IRAS ID

  143826

• Contact name

  K John Pasi

• Contact email

  k.j.pasi@qmul.ac.uk

• Sponsor organisation

  Biogen Idec

• Eudract number

  2013-003013-18

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  South Central - Berkshire Research Ethics Committee

• REC reference

  14/SC/0034

• Date of REC Opinion

  23 Apr 2014

• REC opinion

  Further Information Favourable Opinion